Table 3. The meta-analysis results of association between Cyclooxygenase-2 polymorphisms and hepatocellular carcinoma risk (For Chinese population).
| SNPs | Contrast model | OR(95%CL) | PA | Test for heterogeneity | |
|---|---|---|---|---|---|
| I2 (%) | P | ||||
| −1195G/A | |||||
| A vs G | 1.158(0.972–1.381) | 0.104 | 68.0 | 0.025 | |
| GA vs GG | 1.203(0.987–1.467) | 0.068 | 11.3 | 0.337 | |
| AA vs GG | 1.472(1.180–1.838) | 0.001 | 30.2 | 0.231 | |
| GA+AA vs GG | 1.290(1.069–1.555) | 0.008 | 16.8 | 0.307 | |
| GG+GA vs AA | 0.815(0.621–1.068) | 0.137 | 66.6 | 0.030 | |
| −765G/C | |||||
| C vs G | 1.665(0.783–3.541) | 0.186 | 90.1 | 0.000 | |
| GC vs GG | 1.657(0.747–3.675) | 0.234 | 89.9 | 0.000 | |
| GC+CC vs GG | 1.691(0.757–3.777) | 0.200 | 90.3 | 0.000 | |